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Abstract
Hypertension and myocardial infarction are associated with the onset of hypertrophy. Hypertrophy is a compensatory
response mechanism to increases in mechanical load due to pressure or volume overload. It is characterized by extracellular
matrix remodeling and hypertrophic growth of adult cardiomyocytes. Production of Vascular Endothelial Growth Factor
(VEGF), which acts as an angiogenic factor and a modulator of cardiomyocyte function, is regulated by mechanical stretch.
Mechanical stretch promotes VEGF secretion in neonatal cardiomyocytes. Whether this effect is retained in adult cells and
the molecular mechanism mediating stretch-induced VEGF secretion has not been elucidated. Our objective was to
investigate whether cyclic mechanical stretch induces VEGF secretion in adult cardiomyocytes and to identify the molecular
mechanism mediating VEGF secretion in these cells. Isolated primary adult rat cardiomyocytes (ARCMs) were subjected to
cyclic mechanical stretch at an extension level of 10% at 30 cycles/min that induces hypertrophic responses. Cyclic
mechanical stretch induced a 3-fold increase in VEGF secretion in ARCMs compared to non-stretch controls. This increase in
stretch-induced VEGF secretion correlated with NFkB activation. Cyclic mechanical stretch-mediated VEGF secretion was
blocked by an NFkB peptide inhibitor and expression of a dominant negative mutant IkBa, but not by inhibitors of the
MAPK/ERK1/2 or PI3K pathways. Chromatin immunoprecipitation assays demonstrated an interaction of NFkB with the
VEGF promoter in stretched primary cardiomyocytes. Moreover, VEGF secretion is increased in the stretched myocardium
during pressure overload-induced hypertrophy. These findings are the first to demonstrate that NFkB activation plays a role
in mediating VEGF secretion upon cyclic mechanical stretch in adult cardiomyocytes. Signaling by NFkB initiated in response
to cyclic mechanical stretch may therefore coordinate the hypertrophic response in adult cardiomyocytes. Elucidation of
this novel mechanism may provide a target for developing future pharmacotherapy to treat hypertension and heart disease.
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Introduction
Cardiovascular diseases such as myocardial infarction and
hypertension often present with the development of cardiac
hypertrophy. Hypertrophy is characterized by extracellular matrix
(ECM) remodeling and enhanced growth of adult cardiomyocytes
[1]. Increased mechanical stretch or volume overload promotes
adult cardiomyocyte hypertrophy [2]. In vivo mechanical stretch
induces growth and remodeling within the hemodynamically
overloaded myocardium [3,4]. This can be partially modeled in
vitro when cardiomyocytes are cultured on ECM-coated flexible
membranes and subjected to mechanical stretch that is similar to
stretch overload in vivo [5]. In these assays, mechanical stretch of
cardiomyocytes activates several hypertrophic responses including
increased gene expression of brain natriuretic peptide [BNP] and
atrial natriuretic peptide [6], endothelin-1 [7] and upregulation of
growth factors and cytokines [8,9].
In the heart, Vascular Endothelial Growth Factor (VEGF) is
regulated by environmental stresses such as hypoxia [10] and
mechanical stress [11,12]. Recent studies on VEGF signaling
suggest that while this cytokine promotes angiogenesis, it is also a
primary regulator of cardiomyocyte function [13]. For example,
VEGF levels are elevated in the sera of patients with acute
myocardial infarctions [14] and VEGF preserves cardiac function
post-infarction [13]. In addition, intramyocardial VEGF expres-
sion provides a significant improvement in cardiac function after
permanent coronary artery occlusion via upregulating the genes
that drive the compensatory hypertrophic response [15].
The mechanism of how hypertrophy activates VEGF secretion
in adult cardiomyocytes in vivo or in vitro is unknown. In vitro
mechanical stretch promotes VEGF secretion in neonatal
cardiomyocytes; however the molecular mechanism responsible
for VEGF secretion has not been investigated in these cells
[11,16]. Moreover, whether stretch activates VEGF secretion in
the adult cell and the molecular mechanism mediating stretch-
induced VEGF secretion in either neonatal or adult cardiomyo-
cytes has not been elucidated. Adult cells retain their phenotype
and are less likely to de-differentiate compared to neonatal cells. In
addition, isolated adult cells do not demonstrate general increases
in contractile proteins or ANP that occur in the neonatal
phenotype [17,18]. Thus, hypertrophic signaling in adult cells is
more likely to represent the in vivo state. Therefore, we chose adult
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activated VEGF secretion and to elucidate the molecular
mechanism. We demonstrate here that cyclic mechanical
stretch-induces VEGF secretion via the NFkB signaling pathway
in adult cardiomyocytes.
Materials and Methods
Animals
Experiments were performed on Sprague-Dawley rats (6-8
weeks old, male). Animals were obtained from The Jackson
Laboratory (Bar Harbor, ME). All animals received care in
compliance with the principles of laboratory animal care and use
formulated by the Institutional Animal Care & Use Committee.
Antibodies and Inhibitors
Antibodies directed against phospho-p44/42 MAPK (ERK1/2)
[T
202/Y
204 and T
185/Y
187]X P( #4370), p44/42 MAPK (ERK1/
2) (#4695), phospho-AKT [T
308]( #9275), AKT (#9272),
phospho-IkBa [S
32/S
36]( #9246), or IkBa (#9242) were pur-
chased from Cell Signaling (Danvers, MA). Antibodies directed
against NFkB p65 (#372) or b-actin (#1516) were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal
anti-TATA-binding protein (TBP) (#51841) was purchased from
Abcam (Cambridge, MA). HRP-Goat anti-rabbit IgG (H+L)
Conjugate (#62-1820) and HRP-Goat anti-mouse IgG (H+L)
(#62-6520) were purchased from Invitrogen (Carlsbad, CA).
Secondary antibodies against rabbit (#926-32213) and mouse
(#926-32212) were obtained from LI-COR Biosciences (Lincoln,
NE). All antibodies were diluted in 3%BSA/TBS (0.1% Tween
20) buffer at 1:1000 for the primary, and 1:10000 for the
secondary.
Cell-permeable peptide-inhibitor of the translocation of the
NFkB active complex into the nucleus, SN50 (P-600), and its
inactive peptide-control, SN50M (P-601) were purchased from
ENZO LS (Farmingdale, NY). SN50 and SN50M were dissolved
in media at 15 mg/ml and 30 mg/ml. A selective inhibitor of the
mitogen-activated protein kinase kinases (MAPKK), MEK-1 and
MEK-2, U0126 (U-6770), and a specific inhibitor of phosphati-
dylinositol 3-kinase (PI3K), LY294002 (L-7962), were purchased
from LC Labs (Woburn, MA). U0126 and LY294002 were
dissolved in DMSO.
Cardiomyocyte Isolation and Culture
Primary culture of cardiac myocytes was prepared from the
whole adult rat hearts. The procedure was modified from Piper
et al [19] and optimized to obtain a high yield of viable ARCMs.
Briefly, rats were anesthetized with isofluorane and injected with
200 U heparin (5.4 mg/ml). Hearts were then excised, cannulated,
and perfused for 30 min with perfusion buffer [pH 7.3; containing
HEPES (25 mM), NaCl (110 mM), KCl (2.6 mM), creatine
(5 mM), taurine (20 mM), MgSO4 (1.2 mM), KH2PO4 (1.2 mM)
and glucose (11 mM)] supplemented with collagenase Type II
(6 mg/ml; #17101-015, Invitrogen, Carlsbad, CA). Perfused
hearts were minced in DNase I solution (50 mg/ml #D4513,
Sigma, St. Loius, MO) supplemented with 1% BSA, strained and
layered over a 4% BSA gradient. Sedimented ARCMs were
resuspended in culture media, Medium 199 (#11150, Invitrogen,
Carlsbad, CA) supplemented with HEPES (25 mM), BSA (0.2%),
human insulin (0.6 mg/ml), PenStrep (1%), taurine, creatine and
carnitine. Cells were plated on 6-well culture plates pre-coated
(overnight, 4uC) with 15 mg/ml natural mouse laminin (#23017-
015, Invitrogen, Carlsbad, CA), and incubated at 37uC, 5% CO2.
After 1 h of plating, media was replaced and cells were incubated
for 24 h before the use in the study.
MTT Assay
Viability of cardiomyocytes in culture was assessed using the
MTT assay [20,21]. The assay measures the ability of an active
mitochondrial enzyme to reduce the MTT substrate (yellow to
blue) in live cells. Isolated primary cardiomyocytes were plated in
serum-free conditions on 48-well plates pre-coated with laminin.
After 24 h or 48 h of culture, 0.5 mg/ml MTT substrate
(Thiazolyl Blue Tertrazolium Bromide) was added and cells were
incubated for additional 4 h, and then solubilized with 10% SDS/
HCl (0.01N) overnight. Absorbance was measured at 595 nm.
Cyclic Mechanical Stretch
Flexible-bottomed tissue culture plates (UF-4001U) were
purchased from FlexCell International (Hillsborough, NC). After
a media change, pulsatile stretch of ARCMs was performed in a
Flexcell FX-4000 (V4.0) strain unit at an extension level of 10% at
30 cycles/min for 24 h and 48 h. This procedure has previously
been reported to mimic hypertrophic stress in vitro [9]. During the
duration of stretch, cells were kept in the incubator at 37uC, 5%
CO2. Control (non-stretched) ARCMs were cultured identically
without the stretch. At the conclusion of the experiment, samples
of conditioned culture media were collected for measuring VEGF
levels via ELISA and cell lysates were collected for immunoblot-
ting.
Subcellular Fractionation: Cytoplasmic and Nuclear
Fractions
A stepwise extraction of four distinct subcellular proteomes from
one sample based on their solubility was performed using
ProteoExtract
TM Subcellular Proteome Extraction Kit
(#539790, EMD Chemicals, Gibbstown, NJ). Briefly, stretched
and non-stretched ARCM attached to laminin-coated plates were
sequentially incubated with four extraction buffers, and fractions
containing cytosolic, membrane, nucleic or cytoskeletal proteins
were collected at each step.
Immunoblotting analysis was performed on cytosolic and
nucleic fractions as described below. Equal volume (20–25 ml) of
each fraction was used for analysis. Tata-binding-protein (TBP)
was used as a nuclear fraction marker [22].
Immunoblotting
Immunoblotting analysis was performed as previously described
[23]. Briefly, cell lysates of stretched and non-stretched cardio-
myocytes cultured with or without inhibitors were centrifuged at
14,000 rpm for 15 min. Supernatants containing equal amounts of
total soluble proteins were separated by SDS-PAGE and
transferred to nitrocellulose membranes for immunoblotting with
specific antibodies. Band intensities were quantified by scanning
densitometry.
Adenovirus transduction of Dominant Negative Mutant
IKBa
Twenty-four hours after isolation ARCMs were transduced with
an IkBa dominant negative mutant (IkBa -S32A/S36A; DNM
IkBa) adenovirus (Vector Biolabs, Philadelphia, PA) at 10
8 PFU/
ml or control. Stretch experiments were performed 24 h later.
Culture media was changed and cells were stretched or non-
stretched for an additional 24 h. Media was collected and
analyzed via ELISA for secreted VEGF or BNP levels as described
below. Whole cell lysate or cytoplasmic and nuclear fractions were
Stretch Upregulates VEGF Secretion via NFkB
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for p65-NFkB activity as described above.
Quantification of VEGF or BNP levels in cultured media by
ELISA
Samples of media from stretched and non-stretched primary
cardiomyocytes were collected (1 ml from each well), and
centrifuged at 14,000 rpm for 15 min to pellet off dead cells and
debris. The supernatants were analyzed for the levels of secreted
VEGF protein via Quantikine mouse/rat VEGF ELISA kit
(#MMV00, R&D Systems, Minneapolis, MN) or BNP protein via
AssayMax Rat BNP-32 (rBNP-32) ELISA kit (#ERB1201-1,
AssayPro, Saint Charles, MO) according to the manufacturer
instructions.
The VEGF ELISA kit recognizes both VEGF A and VEGF B
forms.
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assays were performed by using the EZ-ChIP Assay Kit
(Upstate Biotechnologies, Millipore Co. Billerica, MA) following
the manufacturer’s instructions. Briefly, ARCMs were cultured for
24 h and then either stretched or non-stretched for additional
24 h. Next 37% formaldehyde was added directly to the media of
above cultured ARCMs to a final concentration of 1% RT for
10 min to crosslink the proteins to the DNA. Cross-linking was
then stopped by adding 2.5 M glycine to a final concentration of
0.125 M, washed twice in ice cold PBS, scraped, centrifuged to
pellet and re-suspended in SDS lysis buffer containing Protease
Inhibitor Cocktail II. Native chromatin was sonicated to shear
cross-linked DNA to ,200–1000 base pairs in length. Sheared
cross-linked chromatin then was pre-cleared with Protein G
Agarose by incubating for 1 h at 4uC with rotation. After pelleting
agarose by centrifugation, 1% volume of each sample was
removed as ‘‘input fraction’’ (non-immunoprecipitated) and
remaining supernatant was immunoprecipitated (IP) with anti-
bodies against NFkB p65 or control antibodies overnight at 4uC
with rotation. 60 ml of Protein G Agarose was added to recover
protein/DNA complexes at 4uC for 1 h. Beads were pelleted and
washed sequentially in the low salt buffer, high salt buffer, LiCl
wash buffer and Tris-EDTA buffer. Following washing of the
beads, immunoprecipitated protein/DNA complexes were ana-
lyzed via immunoblot analysis with p65 NFkB. Reversal of
protein/DNA crosslinks was carried out by heating samples at
65uC overnight. The elution was then digested with RNAase at
37uC for 30 min and with proteinase K at 45uC for 2 h. DNA was
purified with provided Spin Filters according to the kit
instructions. Real Quantitative PCR (RT-qPCR) was performed
with 10 ml of immunoprecipitated DNA using the following
conditions: 1cycle of 95uC for 2 min, 30cycles of 95uC for 30 sec,
68uC for 5 sec. The primers (designed by Genomics Shared
Resource; University of Hawaii Cancer Center) used were rat
VEGF promoter +420 bp: 59-CGACTGGTCCGATGAAAGAT-
39 Forward (F) and 59-CGAACAGAGAGAGGGACAGG-39
Reverse (R).
Pressure Overload Studies
8-week old males were subjected to ascending aortic constriction
or the sham operation. This model causes LV hypertension and
hypertrophy. Hearts were isolated at 10 days post-surgery,
perfused and fixed in 4& paraformaldehyde (PFA), dehydrated,
and embedded in paraffin. Immunostaining with an anti-VEGF
antibody (Santa Cruz Biotechnologies, Santa Cruz, CA) was
Figure 1. Cyclic mechanical stretch induces VEGF secretion in primary ARCMs. A) Cyclic mechanical stretch for either 24 h or 48 h induces
a significant increase in VEGF secretion in primary ARCMs attached to laminin compared to non-stretched controls. Stretched (10% stretch) and non-
stretched control (0% stretch) cells were allowed to adhere to laminin for 24 h prior to initiating experiments. VEGF concentration in the conditioned
media of non-stretched and stretched ARCMs was analyzed by ELISA. ***P,0.001; One-Way ANOVA with a Bonferroni post-test was used to
determine the statistical significance of data. The values represent the average of three independent experiments. B) Isolated ARCMs remain viable in
culture when attached to laminin. Cell cultures were examined for their ability to reduce MTT after 24 h or 48 h in culture. Fold induction in relative
mitochondrial activity represents the amount of viable cells at each time point. ***P,0.001; One-Way ANOVA with a Bonferroni post-test was used to
determine the statistical significance of data. Insert: The isolation procedure yielded a .90% pure ARCM population. Phase contrast image of
isolated, primary ARCMs 24 h after binding to laminin demonstrate that ARCM differentiated morphology is maintained as indicated by the rod-
shaped, branched striated cell examined at 40X magnification.
doi:10.1371/journal.pone.0029055.g001
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Laboratories, Burlingame, CA).
Statistical Analysis
ELISA and densitometric readings were subjected to statistical
analysis. Differences between the mean values and the densito-
metric readings were analyzed by ANOVA followed by Bonferro-
ni’s test for multiple comparisons between pairs. Values of P,0.05
indicated statistical significance. P-values are abbreviations as
follows, ***P,0.001, **P,0.01, *P,0.05, or non-significant (n.s.).
At least three independent experiments were performed for each
data set and combined for statistical analysis.
Results
Cyclic mechanical stretch promotes VEGF secretion in
adult cardiomyocytes
In vivo cardiomyocytes secrete VEGF upon hypoxia and
mechanical stretch [24]. To investigate whether cyclic mechanical
stretch induced VEGF secretion in vitro, we measured the
concentration of VEGF in the conditioned media from isolated
adult rat cardiomyocytes (ARCMs) subjected to cyclic stretch or
non-stretched controls. ARCMs attached to laminin-coated
flexible-bottomed tissue culture plates were subjected to pulsatile
stretch using a Flexcell FX-4000 (V4.0) strain unit at an extension
level of 10% at 30 cycles/min that was optimized to promote
hypertrophic responses [8,9,25]. Cyclic stretch significantly
increased the concentration of VEGF in the conditioned media
by approximately 2.2-fold at 24 h and 3-fold at 48 h compared to
their respective non-stretch controls (Figure 1A).
To determine if primary ARCMs bound to laminin survive over
time in culture, we assessed cell survival by the MTT assay, which
measures cell viability by detecting the ability of a mitochondrial
enzyme to reduce its substrate as demonstrated by a colorimetric
reaction [20]. ARCMs attached to laminin survive in culture for at
least 3 days (Figure 1B). ARCMs were obtained at .90% purity
and retained their differentiated elongated rod-shaped branched
morphology with distinct striations when plated on a laminin
matrix (Figure 1 insert).
Cyclic mechanical stretch activates the NFkB, MAPK/
ERK1/2 and PI3K pathways in ARCMs
Integrin attachment to the ECM can activate NFkB, MAPK/
ERK1/2, and PI3K pathways [26]. Upon NFkB activation, the
NFkB heterodimer complex including the p65-subunit is translo-
cated to the nucleus where it upregulates a number of genes that
affect cell survival and cardiac hypertrophy. We next examined
whether in vitro hypertrophic cyclic mechanical stretch of adult
cardiomyocytes may directly influence NFkB subcellular distribu-
tionand activity.Cytosolicandnuclearfractionsfromnon-stretched
and stretched ARCMs were blotted with an anti-NFkB p65
antibody. As shown in stretched ARCMs, more NFkB p65 was
present in the nuclear fraction compared to non-stretched controls
(Figure 2A). The Nuclear/Cytosolic (N/C) ratio was increased
Figure 2. Cyclic mechanical stretch activates the NFkB, MAPK/ERK1/2 and PI3K pathways in ARCMs. A) Isolated ARCMs attached to
laminin were subjected to 24 h of cyclic mechanical stretch (10% stretch). Non-stretched control (0% stretch) ARCMs attached to laminin were
incubated under identical conditions. Cells were then lysed, fractionated into cytosolic (C) and nuclear (N) fractions and immunoblotted with an anti-
NFkB p65 antibody. In stretched ARCMs, the nuclear fraction contained significantly more of the NFkB p65 subunit compared to the non-stretched
controls. Relative intensity of nuclear to cytoplasmic (N/C) fraction was determined. An antibody to the anti-TATA-binding protein (TBP) was used to
determine fractionation efficiency. Cyclic mechanical stretch for 24 h induced a significant increase in MAPK/ERK1/2 and PI3K activity in isolated
ARCMs attached to laminin. Isolated ARCMs were allowed to attach to laminin for 24 h and subsequently subjected to 24 h of cyclic mechanical
stretch (10% stretch) or no stretch (0% stretch). Cells were lysed and immunoblotted for (B) ERK1/2 activity using an antibody against phospho-ERK1/
2 (pERK) or a total ERK1/2 antibody (tERK) or for (C) PI3K activity via an antibody against phospho-AKT (pAKT) or total AKT (tAKT). Relative intensity of
pERK/tERK or pAKT/tAKT was determined. *P,0.05; ***P,0.001; One-Way ANOVA with a Bonferroni post-test was used to determine the statistical
significance of data. The values represent the average of three independent experiments.
doi:10.1371/journal.pone.0029055.g002
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cyclic mechanical stretch, NFkB signaling is activated in ARCMs.
Cyclic mechanical stretch induces activation of both MAPK/
ERK1/2 [27,28] and PI3K [29] pathways in neonatal cardiomy-
ocytes. In a similar manner in ARCMs, we found that
hypertrophic cyclic stretch promoted an increase in the activation
of the MAPK/ERK1/2 pathway as indicated by increased
phospho-ERK1/2 (Figure 2B). Cyclic mechanical stretch also
activated the PI3K pathway as demonstrated by an increase in
phospho-AKT levels (Figure 2C). Taken together, we find that in
adult cardiomyocytes cyclic mechanical stretch activates three
primary pathways involved in the hypertrophic responses.
The MAPK/ERK1/2 and PI3K pathways do not regulate
stretch-mediated VEGF secretion
Because both the MAPK/ERK1/2 pathway and the PI3K
pathway regulate VEGF expression in a cell type specific manner
[30], we next examined whether either pathway was involved in
promoting stretch-induced VEGF secretion in ARCMs. Chemical
inhibitors against each pathway were tested in our in vitro system.
ARCMs bound to laminin were treated with either the ERK1/2
kinase inhibitor (U0126) or the PI3K inhibitor (LY294002), and
subjected to 24 h or 48 h of cyclic mechanical stretch. Neither
inhibition of ERK1/2 nor of PI3K abrogated the stretch-induced
increase in VEGF secretion (Figure 3A, C). The ERK1/2 and
PI3KinhibitorswereactiveinprimaryARCMsastreatmentofthese
cells with either the ERK1/2 or PI3K inhibitor over 24 h
significantly attenuated phospho-ERK1/2 (Figure 3B) and phos-
pho-AKT levels (Figure 3D). To confirm that these inhibitors were
active in these cells and that these pathways are important in
hypertrophic signaling we also examined whether expression of
BNP,a known marker of hypertrophy, was decreased upon inhibitor
treatment. In agreement with published findings, the ERK1/2 and
PI3KinhibitorssignificantlydecreasedBNPexpression(Figure3E).
Taken together, these findings suggest that neither the MAPK/
ERK1/2 nor the PI3K pathway is involved in cyclic mechanical
stretch-induced secretion of VEGF in ARCMs but may be involved
in the regulation of other hypertrophic signaling pathways.
Inhibiting the NFkB pathway blocks mechanical stretch-
induced VEGF secretion in adult cardiomyoyctes
VEGF secretion is dependent upon activation of the NFkB
pathway in mesenchymal stem cells [31]. To investigate whether
NFkB mediates stretch-induced secretion of VEGF in primary
ARCMs, cells were treated with an NFkB peptide inhibitor or its
inactive control peptide, and subjected to 24 h and 48 h of
hypertrophic cyclic mechanical stretch (Figure 4A–B). Blocking
the NFkB pathway resulted in a significant reduction of stretch-
mediated VEGF secretion in ARCMs compared to non-stretched
controls at 24 h and 48 h (Figure 4A–B). Furthermore, the NFkB
inhibitor blocked stretch-mediated VEGF secretion in a dose
dependent manner (Figure 4C–D). ARCMs treated with an
NFkB inhibitor or its inactive control peptide remained viable
after 24 h and 48 h in culture (Figure 4E–F) as determined by
the MTT assay. The NFkB inhibitor was active in primary
Figure 3. Cyclic mechanical stretch-induced VEGF secretion is
independent of the MAPK/ERK1/2 or PI3K pathways. Inhibition
of either the MAPK/ERK1/2 or PI3K signaling pathways in isolated
ARCMs did not block VEGF secretion induced by cyclic mechanical
stretch. Isolated ARCMs attached to laminin for 24 h were treated with
the ERK1/2 kinase inhibitor (U0126; 0.5 mM) or DMSO-carrier control and
subjected to (A) 24 h or 48 h of cyclic mechanical stretch (10% stretch)
or no stretch (0% stretch). ELISA was used to determine the amount of
VEGF secreted into the media. (B) The ERK1/2 kinase inhibitor was
active in isolated primary ARCMs as pERK1/2 levels decreased in cells
treated with the ERK1/2 kinase inhibitor (U0126; 0.5 mM) compared to
the DMSO-carrier control. Stretch-activated VEGF secretion is indepen-
dent of PI3K. ARCMs attached to laminin for 24 h were treated with the
PI3K inhibitor (LY294002; 0.5 mM) or DMSO-carrier control and
subjected to 24 h or 48 h (C) of cyclic mechanical stretch (10% stretch)
or no stretch (0% stretch). ELISA was used to determine the amount of
VEGF secreted into the media. (D) The PI3K inhibitor (LY294002; 0.5 mM)
was active in isolated ARCMs as pAKT levels decreased in cells treated
with the PI3K inhibitor (LY294002; 0.5 mM) compared to the DMSO-
carrier control. Relative intensity of phospho-ERK1/2/total ERK1/2
(pERK/tERK) or phospho-AKT/total AKT (pAKT/tAKT) was determined.
(E) ELISA was used to determine the amount of BNP secreted into the
media. Treatment with the either ERK1/2 (U0126) or PI3K (LY294002)
inhibitors blocked BNP secretion at 24 hours compared to DMSO-carrier
control. ***P,0.001; One-Way ANOVA with a Bonferroni post-test was
used to determine the statistical significance of data. n.s.=not
significant. The values represent the average of three independent
experiments.
doi:10.1371/journal.pone.0029055.g003
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Primary ARCMs cultured on laminin for 24 h were incubated with the NFkB inhibitor (SN50; 15 mg/ml) or its inactive control peptide (SN50M; 15 mg/
ml), and subjected to 24 h or 48 h of cyclic mechanical stretch (10% stretch). Non-stretched control cells (0% stretch) were incubated under identical
conditions. ELISA was used to analyze VEGF levels secreted into the culture media at 24 h (A)o r4 8h( B). Inhibition of the NFkB pathway blocks cyclic
mechanical stretch-induced VEGF secretion in a dose-dependent manner. Isolated primary ARCMs cultured on laminin were treated with NFkB
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inhibitor significantly attenuated p65 nuclear translocation
(Figure 4G).
We next used adenoviral gene transduction of a dominant
negative mutant IkB to unequivocally demonstrate the involve-
ment of NFkB signaling in the induction of stretch-mediated
Figure 5. Expression of a dominant negative mutant IkBa blocks cyclic mechanical stretch-induced VEGF secretion in a dose-
dependent manner. Primary ARCMs transduced with a recombinant adenovirus encoding an IkBa dominant negative mutant (DN IkBa) were
cultured on laminin for 24 h and then subjected to 24 h of cyclic mechanical stretch (10% stretch). Non-stretched control cells (0% stretch) were
incubated under identical conditions. ELISA was used to determine VEGF levels secreted into the culture media at 24 h (A). (B) Expression of the IkBa
dominant negative mutant blocks cyclic mechanical stretch-induced VEGF secretion in a dose-dependent manner. ELISA was used to analyze the
concentration of VEGF in the media. (C) The IkBa dominant negative mutant was expressed in isolated ARCMs as IkBa levels were significantly
increased in ARCMs expressing the mutant compared to control ARCMs. (D) The IkBa dominant negative mutant was active in isolated ARCMs as p65
levels were significantly decreased in the nucleus of ARCMs expressing the mutant compared to control ARCMs. ***P,0.001; One-Way ANOVA with a
Bonferroni post-test was used to determine the statistical significance of data. n.s.=not significant. The values represent the average of three
independent experiments. (E) Representative ChIP assay PCR showing hypertrophic stretch increases NFkB binding to the native VEGF promoter in
ARCMs. Protein-DNA complexes were immunoprecipitated with an NFkB p65 antibody followed by DNA isolation and purification and PCR. Non-
immunoprecipitated chromatin was used as an ‘‘input’’ control (-). ARMCs subjected to 24 h stretch (10%) resulted in increased binding of NFkB to
the VEGF promoter over 0% stretch.
doi:10.1371/journal.pone.0029055.g005
inhibitor (SN50; 15 mg/ml or 30 mg/ml) and stretched (10% stretch) for 24 h (C)o r4 8h( D). ELISA was used to analyze the concentration of VEGF in
the media. Isolated primary ARCMs treated with the NFkB inhibitor (SN50) or its inactive peptide control (SN50M) remained viable at 24 h (E) and
48 h (F) of culture as assessed by the MTT cell viability assay. Fold induction in relative mitochondrial activity represents the number of viable cells
present after each treatment. (G) The NFkB peptide inhibitor (SN50) was active in isolated ARCMS as p65 levels were reduced in the nuclear fraction
upon inhibitor treatment compared to peptide control. ***P,0.001; One-Way ANOVA with a Bonferroni post-test was used to determine the
statistical significance of data. n.s.=not significant. The values represent the average of three independent experiments.
doi:10.1371/journal.pone.0029055.g004
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transduced with a recombinant adenovirus encoding a dominant
negative mutant form of IkBa or control and assayed for IkBa
expression (Figure 5C). ARCMs expressing dominant negative
IkBa were then subjected to 24 h of hypertrophic cyclic
mechanical stretch. Inhibiting the NFkB pathway in this manner
resulted in a significant reduction of stretch-mediated VEGF
secretion in ARCMs compared to control at 24 h (Figure 5A).
Furthermore, expression of dominant negative mutant IkB (DNM
IkBa) blocked stretch-mediated VEGF secretion in a dose-
dependent manner (Figure 5B). Infection of primary ARCMs
with DNM IkBa significantly attenuated p65 nuclear transloca-
tion, indicating that it was active in these cells (Figure 5D). These
findings support the hypothesis that stretch-induced VEGF
secretion is mediated, at least in part, by the NFkB signal
transduction pathway.
Finally, ChIP was used to determine whether hypertrophic
stretch increases NFkB binding to the native VEGF promoter.
Protein-DNA complexes were immunoprecipitated with an NFkB
p65 antibody followed by DNA isolation, purification and PCR.
Non-immunoprecipitated chromatin was used as an ‘‘input’’
control, and an IgG antibody control was performed on all
occasions. PCR primers (VEGF promoter +420) were designed to
cover only the fragment known to containing the two NFkB [32].
ARMCs subjected to 24 h stretch resulted in increased binding of
NFkB to the VEGF promoter over IgG antibody control and 0%
stretch (Figure 5E).
VEGF expression is enhanced in vivo in the myocardium
upon pressure overload induced hypertrophy
Because the NFkB pathway is required for cardiomyocyte
hypertrophic growth [33], we examined whether VEGF expression
is enhanced in vivo in the myocardium upon induction of
hypertrophy. Pressure overload-induced hypertrophy resulted in
increased VEGF staining within the myocardium and in cardio-
myocytes compared to Sham controls (Figure 6). This finding is in
agreement with the literature that VEGF is involved in cardiomy-
ocyte function and the hypertrophic response[13,14,15].
Discussion
The present study demonstrates for the first time that
hypertrophic mechanical stretchpromotesVEGF secretion through
the NFkB signal transduction pathway in adult rat cardiomyocytes.
Blocking NFkB activation abrogates VEGF secretion induced by
cyclic mechanical stretch in these cells. This is the first report to
show a role for cyclic mechanical stretch in mediating VEGF
secretion in adult cardiomyocytes. Moreover, this is the first
demonstration that cyclic mechanical stretch promotes VEGF
secretion through activation of the NFkB signaling pathway.
Stretch induced activation of NFkB is likely downstream of integrins
b e c a u s ew es e ea ni n c r e a s ei nF A Ka c t ivation in adult cardiomyocytes
(data not shown) which is in agreement with previous findings in
neonatal cardiomyocytes [16,34]. Activation of the NFkB pathway is
dependent upon the degradation of the inhibitory IkB protein and
subsequent translocation of the NFkB complex to the nucleus where it
activates gene transcription. We found that cyclic mechanical stretch
promoted the nuclear translocation of NFkB and increased VEGF
secretion in adult cardiomyocytes. Inhibition of NFkB signaling
blocked stretch-mediated VEGF secretion. The NFkB pathway is
involved in regulating the immediate early genes and is required for
cardiomyocyte hypertrophic growth [33]. NFkB may promote
cardiomyocyte growth by binding to the two NFkB recognition sites
in the VEGF promoter [32]. Indeed, we demonstrate that in ARCMs
subjected to stretch there is increased binding of NFkB to the VEGF
promoter over non-stretch controls as determined by ChIP analysis. In
our in vitro model system of stretch-induced hypertrophy [8,9,25] we
found that NFkB activation is necessary for cyclic mechanical stretch-
induced VEGF secretion. Hypoxia-induced stress also promotes
NFkB-mediated VEGF secretion in human mesenchymal stem cells
[31]. We now add that cyclic mechanical stretch promotes VEGF
secretion via activation of the NFkB pathway in adult cardiomyocytes.
The MAPK/ERK1/2 and PI3K signal transduction pathways
can also regulate VEGF expression, activate NFkB signaling and
are activated in response to mechanical stretch in neonatal
cardiomyocytes [27,28,29]. Our data indicate that in adult
cardiomyocytes cyclic mechanical stretch activates both the
MAPK/ERK1/2 and PI3K pathways. However, inhibiting these
Figure 6. VEGF expression is enhanced in the myocardium and in cardiomyocytes upon pressure overload-induced hypertrophy in
vivo. Immunostaining for VEGF using a polyclonal anti-VEGF antibody in paraffin fixed heart tissue from a pressure-overload hypertrophy model or
sham control at day 10. Box= higher magnification inset. Representative of three independent experiments.
doi:10.1371/journal.pone.0029055.g006
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ARCMs remained viable over 48 h with the addition of MAPK/
ERK1/2 or PI3K inhibitors. These findings suggest that while
both the MAPK/ERK1/2 and PI3K pathways may be involved in
cyclic mechanical stretch mediated events such as BNP secretion,
they are unlikely to be key modulators of stretch-induced VEGF
secretion in adult cardiomyocytes. Interestingly, TGF-beta is
secreted during stretch [12] and it has been previously reported
that stretch-induced VEGF expression in rat neonatal cardiomy-
ocytes is, at least in part, mediated by TGF-beta signaling [11,35].
Here we show that stretch of adult rat cardiomyocytes promotes
VEGF secretion via NFkB. TGF-beta activates the NFkB,
MAPK/ERK1/2, and PI3K signaling pathways. Therefore, based
on our data stretched-induced TGF-beta may activate VEGF
secretion through its effects on NFkB. Taken together, our data
suggest that the NFkB pathway plays a key role in regulating
VEGF secretion in response to mechanical stretch.
VEGF is now considered a key modulator of cardiomyocyte
function and the hypertrophic response. Both hypoxia and mechan-
ical stress impact VEGF levels in vivo [13] and we found that pressure
overload-induced hypertrophy increased VEGF expression in the
myocardium in vivo. Taken together, our data indicate that cyclic
mechanical stretch induces VEGF secretion in an NFkB-dependent
manner in adult cardiomyocytes. Therefore, NFkB activation may
play a central role in mediating VEGF secretion in response to
hypertrophic stresses in the heart. Targeting this pathway may
alleviate the pathological effects of hypertrophy and increase survival
of patients presenting with hypertension or post-myocardial infarction.
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